CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
PGX Technology
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGX
Stock Information CZO
TSX Venture
CZO
Change
Volume
Day Range
52 Week Range
Stock Information CRPOF
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Corporate Presentation
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View Presentation
Products
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Latest News
Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update
May 25, 2023 | Read More
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases
May 23, 2023 | Read More
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration
May 3, 2023 | Read More
Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations
Apr 27, 2023 | Read More